LGC acquired the leading bioanalytical business from Quotient Bioresearch in December 2012. All services offered by Quotient Bio Analytical Sciences now form part of the LGC Group. For enquiries relating to bioanalysis, biomarkers, central lab, molecular biology and microbiology please contact LGC. To be directed to the LGC website, please visit: LGC
Quotient Scientists attend the Antibody Engineering and Therapeutics Conference
53rd Society of Toxicology Annual Meeting and ToxExpo 2014: March 23rd - 27th 2014. Phoenix Convention Centre, Phoenix, Arizona.
Read Quotient Metabolism latest research article published on Informa Healthcare titled: Absorption, metabolism and excretion of [14C]gemigliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans